Bringing neuromodulation therapeutics from the hospital, to the home of the patients.
Actipulse Neuroscience (YC W22) has raised $500K in total funding. The most recent round was Seed. The last funding was announced in January 2022.
Actipulse Neuroscience (YC W22)'s investors include Y Combinator, MassChallenge, Start-Up Chile, Trav Walkowski.
Actipulse Neuroscience (YC W22) is headquartered in Cambridge, United States.
Bringing neuromodulation therapeutics from the hospital, to the home of the patients.
Actipulse Neuroscience (YC W22) is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Actipulse Neuroscience (YC W22) — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/actipulse-neuroscience-yc-w22. Accessed October 18, 2026.
VCBacked. (2022). Actipulse Neuroscience (YC W22) — Funding & Investors. Retrieved October 18, 2026, from https://www.vcbacked.co/company/actipulse-neuroscience-yc-w22
{{cite web |title=Actipulse Neuroscience (YC W22) — Funding & Investors |url=https://www.vcbacked.co/company/actipulse-neuroscience-yc-w22 |website=VCBacked |access-date=October 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated